RT Book, Section
A1 Patel, Manesh R.
A1 Singh, Mandeep
A1 Gersh, Bernard J.
A1 O’Neill, William
A2 Fuster, Valentin
A2 Harrington, Robert A.
A2 Narula, Jagat
A2 Eapen, Zubin J.
SR Print(0)
ID 1161730249
T1 ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
T2 Hurst's The Heart, 14e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071843249
LK accesscardiology.mhmedical.com/content.aspx?aid=1161730249
RD 2024/04/19
AB Ischemic  heart  disease  is  the  leading  cause  of  morbidity  and  mortality  in  Western  society  and  is  a  worldwide  epidemic.  In  2008,  it  was  estimated  that,  worldwide,  ischemic  heart  disease  was  responsible  for  12.7%  of  all  deaths  (7.25  million  total).  Low-income  countries  now  account  for  80%  of  all  deaths;  mortality  is  falling  in  high-income  countries.1  Approximately  1,100,000  Americans  suffer  from  an  acute  coronary  syndrome  (ACS)  per  year,  nearly  one-third  of  which  are  caused  by  an  acute  ST-segment  elevation  myocardial  infarction  (STEMI).2  The  incidence  of  acute  myocardial  infarction  (AMI)  has  declined  over  the  past  two  decades  from  244  per  100,000  population  in  1975  to  162  per  100,000  population  in  2006.3  The  in-hospital  mortality  also  has  declined  from  18%  in  1975  to  10%  in  2006.4  Despite  these  improvements,  AMI  continues  to  be  a  major  public  health  problem,  and  it  has  been  estimated  that  the  number  of  years  of  life  lost  because  of  an  AMI  is  17.1  years,  and  the  cost  to  American  society  (both  direct  and  indirect)  is  $165.4  billion  per  year.2